Eton Pharmaceuticals (ETON) Cash from Investing Activities (2020 - 2025)

Eton Pharmaceuticals has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$49000.0 for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at -$49000.0, up 99.87% year-over-year; the trailing twelve-month figure through Dec 2025 was -$333000.0 (up 99.17% YoY), and the FY2025 annual result was -$333000.0, up 99.17% from the prior year.
• Cash from Investing Activities came in at -$49000.0 for Q4 2025 at Eton Pharmaceuticals, up from -$284000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q3 2021 to a low of -$38.1 million in Q4 2024.
• The 5-year median for Cash from Investing Activities is -$761000.0 (2022), against an average of -$4.3 million.
• Across the five-year window, Cash from Investing Activities plunged 99900.0% in 2022 and jumped 99.87% in 2025, its largest moves.
• Eton Pharmaceuticals' Cash from Investing Activities stood at -$3.3 million in 2021, then surged by 99.63% to -$12000.0 in 2022, then plunged by 6358.33% to -$775000.0 in 2023, then slumped by 4820.26% to -$38.1 million in 2024, then soared by 99.87% to -$49000.0 in 2025.
• The last three Cash from Investing Activities figures came in at -$49000.0 (Q4 2025), -$284000.0 (Q3 2025), and -$38.1 million (Q4 2024), per Business Quant data.